Galantamine, a centrally acting acetylcholinesterase inhibitor, is widely used to treat cognitive deficits in Alzheimer’s diseases (Bullock, 2004). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.